European Commission approves ADCETRIS® (Brentuximab vedotin) for the treatment of adult patients with newly diagnosed...

Lilly presents first clinical data for its investigational, next-generation FRα targeting ADC in platinum-resistant ovarian...

Avenzo Therapeutics Initiates Phase 1/2 Clinical Study of AVZO-1418, a Potential Best-in-Class, Novel EGFR/HER3 Bispecific...

Trodelvy® Plus Keytruda® Reduces Risk of Disease Progression or Death by 35% Versus Keytruda and...

ENHERTU® Plus Pertuzumab reduced the risk of disease progression or death by 44% xersus THP...

LigaChem Biosciences inks dual antibody licensing deals with NovaRock for ADC drug development